Surveyor Capital

143 employees

Surveyor Capital is an investment firm that focuses on access and opportunity to companies and entrepreneurs.

Investor insights

Sectors invested in

Biotechnology102

Health Care70

Therapeutics43

Pharmaceutical42

Medical35

Biopharma24

Life Science22

biotechnology8

Health Diagnostics7

oncology6

drug development5

Cancer4

Medical Device3

Wellness3

small molecules3

Oncology3

Immuno-Oncology3

research3

biotech3

Precision Medicine2

Funding rounds participated in

$100M sweet spot round size

Most of their 111 investments are in rounds between $80M and $120M

Investor type

Hedge Fund

Basic info

Industry

financial services

Sectors

Financial Services

Financial Exchanges

Finance

Date founded

2008

Investments made

Avalyn Pharma Inc. raised $175M on September 27, 2023

Investors: Vida Ventures, LLC, Novo Holdings, S.R. One Ltd, Wellington Management, RiverVest Venture Partners, Perceptive Advisors and Surveyor Capital

Mariana Oncology raised $175M on September 7, 2023

Investors: Nextech Invest, Forbion, Atlas Ventures, RA Capital Management, L.P. and Surveyor Capital

Rapport Therapeutics raised $150M on August 23, 2023

Investors: Logos Global Management, LP, Goldman Sachs Asset Management, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Third Rock Ventures, Perceptive Advisors and Surveyor Capital

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Logos Global Management, LP, TCG X, Armistice Capital LLC and Surveyor Capital

AN2 Therapeutics raised $70M on August 15, 2023

Investors: TCG X, Avidity Partners, Adage Capital Management, RA Capital Management, L.P., Marshall Wace and Surveyor Capital

Lyra Therapeutics raised $50M on May 26, 2023

Investors: Armistice Capital LLC, Woodline Partners LP, Samsara BioCapital, Perceptive Advisors and Surveyor Capital

OnKure Therapeutics raised $54M on May 23, 2023

Investors: Acorn Bioventures, Samsara BioCapital, Perceptive Advisors and Surveyor Capital

Quanta Therapeutics raised $51M on May 22, 2023

Investors: Sofinnova Ventures, Russia technology fund, Longitude Capital, Avidity Partners, Vida Ventures, LLC and Surveyor Capital

Boundless Bio raised $100M on May 16, 2023

Investors: Nextech Invest, Sectoral Asset Management, Partner Fund Management, Redmile Group, Leaps by Bayer, Vertex Ventures HC, Logos Global Management, LP, RA Capital Management, L.P., Wellington Management and Surveyor Capital

Entact Bio raised $81M on December 6, 2022

Investors: Qiming Venture Partners USA, Logos Global Management, LP, venBio Partners, Brandon Capital Partners, Abingworth and Surveyor Capital